Skip to main content

Site notifications

(Approval lapsed) LANOXIN digoxin 0.5mg injection ampoules (UK)

Section 19A approved medicine
(Approval lapsed) LANOXIN digoxin 0.5mg injection ampoules (UK)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 430
Phone
1300 077 674
Approved until
Status
Expired
Medicines in short supply/unavailable
LANOXIN ADULT digoxin 500microgram/2mL injection ampoule - ARTG 11106
Indication(s)

Congestive heart failure - Lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle or involves both sides of the heart. It is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. Lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency.

Atrial fibrillation - Because Lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. It will frequently convert atrial flutter into fibrillation, and, upon withdrawal of the drug, normal sinus rhythm may be restored.

Paroxysmal atrial tachycardia - Lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Images
Picture of LANOXIN digoxin 0.5mg injection ampoules (UK)

Help us improve the Therapeutic Goods Administration site